Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies

• Published in: Advanced Therapeutics Vol. 4; no. 3; p. 2000173
• Main Authors: Hadisi, Zhina, Walsh, Tavia, Dabiri, Seyed Mohammad Hossein, Seyfoori, Amir, Hamdi, David, Mirani, Bahram, Pagan, Erik, Jardim, Armando, Akbari, Mohsen
• Format: Journal Article Web Resource
• Language: English
• Published: Germany John Wiley & Sons, Inc 01.03.2021
• Subjects: SARS; treatment strategies; COVID 19; MERS; coronavirus disease 2019
• DOI: 10.1002/adtp.202000173

Following the emergence of severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012, the world is now combating a third large-scale outbreak caused by a coronavirus, the coronavirus disease 2019 (COVID-19). After the rapid spread of SARS-coronavirus (CoV)-2 (the virus causing COVID-19) from its origin in China, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. From the beginning of the COVID-19 pandemic, a significant number of studies have been conducted to better understand the biology and pathogenesis of the novel coronavirus, and to aid in developing effective treatment regimens, therapeutics, and vaccines. This review focuses on the recent advancements in the rapidly evolving areas of clinical care and management of COVID-19. The emerging strategies for the diagnosis and treatment of this disease are explored, and the development of effective vaccines is reviewed.